Showing results (3441-3450 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|April 18, 2017
Therapeutic Potential of Heme Oxygenase-1/carbon Monoxide System Against Ischemia-Reperfusion InjuryYuanyuan Cheng, Jianhui RongCurrent Pharmaceutical Design|February 28, 2017
Global Effects of Early Life Stress on Neurons and Glial CellsZulma Duenas, Juan Carlos Caicedo-Mera, Luz TornerCurrent Pharmaceutical Design|June 10, 2008
Erythropoietin: new approaches to improved molecular designs and therapeutic alternativesN Debeljak, A J SytkowskiCurrent Pharmaceutical Design|June 10, 2008
Non-invasive tests in animal models and humans: a new paradigm for assessing efficacy of biologics including prebiotics and probioticsR N ButlerCurrent Pharmaceutical Design|June 10, 2008
Probiotics in intestinal and non-intestinal infectious diseases--clinical evidenceK Hatakka, M SaxelinCurrent Pharmaceutical Design|June 10, 2008
Genomics can advance the potential for probiotic cultures to improve liver and overall healthDaniel J O'SullivanCurrent Pharmaceutical Design|June 10, 2008
Life under stress: the probiotic stress response and how it may be manipulatedB M Corcoran, C Stanton, G Fitzgerald, et al.Current Pharmaceutical Design|June 10, 2008
A critical evaluation of adenosine A2A receptors as potentially "druggable" targets in Huntington's diseasePatrizia Popoli, David Blum, Maria Rosaria Domenici, et al.Current Pharmaceutical Design|April 2, 2019
Visit-to-visit Blood Pressure Variability and Arterial Stiffness: Which Came First: The Chicken or the Egg?Shunsuke Miyauchi, Michiaki Nagai, Keigo Dote, et al.Current Pharmaceutical Design|April 2, 2019
The Low Molecular Weight Brain-derived Neurotrophic Factor Mimetics with Antidepressant-like ActivityTatiana A Gudasheva, Polina Povarnina, Alexey V Tarasiuk, et al.Pageof 1,008